JP2002542248A5 - - Google Patents

Download PDF

Info

Publication number
JP2002542248A5
JP2002542248A5 JP2000612301A JP2000612301A JP2002542248A5 JP 2002542248 A5 JP2002542248 A5 JP 2002542248A5 JP 2000612301 A JP2000612301 A JP 2000612301A JP 2000612301 A JP2000612301 A JP 2000612301A JP 2002542248 A5 JP2002542248 A5 JP 2002542248A5
Authority
JP
Japan
Prior art keywords
pharmaceuticals
prevention
treatment
acceptable salt
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000612301A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002542248A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2000/003388 external-priority patent/WO2000063211A1/en
Publication of JP2002542248A publication Critical patent/JP2002542248A/ja
Publication of JP2002542248A5 publication Critical patent/JP2002542248A5/ja
Withdrawn legal-status Critical Current

Links

JP2000612301A 1999-04-17 2000-04-14 ハロアルコキシイミダゾナフチリジン Withdrawn JP2002542248A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99107688.6 1999-04-17
EP99107688 1999-04-17
PCT/EP2000/003388 WO2000063211A1 (en) 1999-04-17 2000-04-14 Haloalkoxy imidazonaphthyridines

Publications (2)

Publication Number Publication Date
JP2002542248A JP2002542248A (ja) 2002-12-10
JP2002542248A5 true JP2002542248A5 (enExample) 2007-05-10

Family

ID=8237986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000612301A Withdrawn JP2002542248A (ja) 1999-04-17 2000-04-14 ハロアルコキシイミダゾナフチリジン

Country Status (12)

Country Link
US (1) US6503923B1 (enExample)
EP (1) EP1173439B1 (enExample)
JP (1) JP2002542248A (enExample)
AT (1) ATE240956T1 (enExample)
AU (1) AU3966600A (enExample)
CA (1) CA2370231A1 (enExample)
DE (1) DE60002855T2 (enExample)
DK (1) DK1173439T3 (enExample)
ES (1) ES2199810T3 (enExample)
PT (1) PT1173439E (enExample)
SI (1) SI1173439T1 (enExample)
WO (1) WO2000063211A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002034749A1 (en) 2000-10-25 2002-05-02 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
WO2002069968A1 (en) * 2001-03-08 2002-09-12 Astrazeneca Ab New use
HUP0400379A3 (en) 2001-08-02 2007-10-29 Altana Pharma Ag Tricyclic epoxides and their use for the preparation of pharmaceutically active agents
US20040235882A1 (en) * 2001-08-03 2004-11-25 Jorg Senn-Bilfinger Amino-substituted imidazopyridines for the treatment of gastrointestial diseases
WO2003016310A1 (en) * 2001-08-03 2003-02-27 Altana Pharma Ag Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders
EA008375B1 (ru) 2002-02-15 2007-04-27 Алтана Фарма Аг Трициклические n-ацильные соединения
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
CN100384842C (zh) 2002-11-19 2008-04-30 奥坦纳医药公司 8-取代的咪唑并吡啶类化合物
CN1747731A (zh) * 2003-02-17 2006-03-15 艾塔那法玛公司 含有咪唑并吡啶的组合和其在治疗胃肠炎性病症中的用途
RS52908B (sr) 2003-03-10 2014-02-28 Takeda Gmbh Novi postupak za dobijanje roflumilasta
AU2004243444A1 (en) * 2003-05-27 2004-12-09 Altana Pharma Ag Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
CA2544325A1 (en) 2003-11-03 2005-05-12 Astrazeneca Ab Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux
AR046893A1 (es) * 2003-12-16 2005-12-28 Altana Pharma Ag Bencimidazoles triciclicos
EP1697358A1 (en) 2003-12-19 2006-09-06 Altana Pharma AG Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
AR047605A1 (es) * 2004-02-17 2006-01-25 Altana Pharma Ag Imidazopiridinas triciclicas e intermediarios en la sintesis de las mismas,sus procesos de preparacion,composiciones farmaceuticas que los contienen y usos.
US7931659B2 (en) * 2004-09-10 2011-04-26 Penumbra, Inc. System and method for treating ischemic stroke
CA2582256A1 (en) * 2004-10-01 2006-04-13 Altana Pharma Ag Substituted tricyclic benzimidazoles
CA2601250C (en) * 2005-03-16 2014-10-28 Nycomed Gmbh Taste masked dosage form containing roflumilast

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
IL108520A (en) 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
HUP0001555A3 (en) 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
HUP0102990A3 (en) 1998-09-23 2002-09-30 Altana Pharma Ag Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof

Similar Documents

Publication Publication Date Title
JP2002542248A5 (enExample)
USD624176S1 (en) Full face mask
USD470329S1 (en) Bed
NO2020019I1 (no) Maraviroc eventuelt i form av et farmasøytisk akseptabelt salt
USD533668S1 (en) Magnetic therapeutic elbow brace
USD488478S1 (en) Front face of a combined personal digital assistant and navigation device
USD471628S1 (en) Medical vial
JP2003503454A5 (enExample)
NO2017047I1 (no) Tofacitinib, evt. i form av et farmasøytisk akseptabelt salt, inkludert citratsalt
NO2012009I1 (no) Kombinasjonsprodukt av saxaglipin og metformin og farmasøytisk akseptable salter frav, herunder HCI saltene av saxaglipin og metformin
WO2004056337A3 (en) Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
NO2013004I1 (no) axitinib, valgfritt i form av et farmasøytisk aksentabelt salt
WO2006102446A3 (en) Multi-particulate, modified-released colonic composition
ID30225A (id) Tablet matriks yang memungkinkan pelepasan yang diperlama dari gliklazida setelah pemberian secara oral
JP2005507892A5 (enExample)
IL152479A0 (en) Pharmaceutical form of administration for peptides, methods for its production and use
HRP20050371A2 (en) Administration form for pharmaceutically active peptides with sustained release and method for the production thereof
USD540657S1 (en) W foot anchor
JP2001513504A5 (enExample)
DK1225902T3 (da) Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden
USD657863S1 (en) Mask
PT1131297E (pt) Certas caprolactamas substituidas composicoes farmaceuticas contendo-as e sua utilizacao no tratamento de tumores
USD450946S1 (en) Bed
USD414401S (en) Cam tie down buckle
USD454719S1 (en) Bed